Aurelius Health Group review

Aurelius is the purest expression of this category on the board: a physician-titrated microdose tirzepatide protocol is the only thing it sells, so there is no full-dose ladder waiting to absorb you and no membership stacked underneath the medication. A board-certified physician reviews the intake inside a day and issues a written plan and titration schedule, and one care-inclusive figure covers the protocol, the consultations, shipping and monitoring. The reservation is not commercial, it is evidential. Its homepage argues the case with a comparison table of expected nausea rates, lean-mass retention and result ranges at a microdose — figures its own footnotes concede are extrapolated from dose-ranging and observational data rather than measured on the protocol being sold. Printing the footnote is to its credit; leading with the table is the overreach this site exists to name.

⚠ The homepage prints expected nausea rates, lean-mass retention and result ranges for a 1 mg microdose — figures extrapolated from full-dose and observational data, not measured on the protocol being sold, which is exactly the overreach this site was built to flag

A single-product practice: physician-titrated microdose tirzepatide, with a board-certified MD or DO reviewing the intake inside 24 hours and issuing a written plan and titration schedule. There is no full-dose ladder to be upsold onto, which removes the usual pressure a microdoser feels on a general platform, and the price is one care-inclusive figure rather than a medication rate with consults and shipping billed underneath. The reservation is not the price. It is that the site argues its case with a comparison table of expected results at a 1 mg microdose, sourced to observational and dose-ranging data rather than to any trial of the protocol it sells.

Pricing structure

Varies by dose, plan or tier

Consult

Included in the price

Compounding

Not publicly identified

Labs

Not required

Dietitian support

Not included

• Microdosing is the entire product rather than the entry rung of a weight-loss ladder, so there is nothing to be titrated up into
• One care-inclusive monthly price covering the protocol, consultations, shipping and monitoring, with no membership stacked underneath
• A board-certified MD or DO reviews the intake within 24 hours and issues a written plan and titration schedule
• The intro month lowers the cost of finding out whether a microdose suits you at all
• Its own footnotes admit the microdose figures are not Aurelius trial data and that large-scale RCT data at sub-therapeutic doses is limited

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• Tirzepatide only, injectable only — there is no semaglutide option and no needle-free route
• The $89 is a single introductory month; the standing rate is more than double it
• Neither the compounding pharmacy nor any individual physician is named on the public site

Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing tirzepatide
• Low dose vs full dose
• Titration planner
• Microdose & reconstitution calculator

Aurelius Health Group is one of 32 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.